GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GL Brands Inc (OTCPK:GRLB) » Definitions » Sloan Ratio %

GL Brands (GL Brands) Sloan Ratio % : -114.50% (As of Sep. 2019)


View and export this data going back to 2013. Start your Free Trial

What is GL Brands Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

GL Brands's Sloan Ratio for the quarter that ended in Sep. 2019 was -114.50%.

As of Sep. 2019, GL Brands has a Sloan Ratio of -114.50%, indicating earnings are more likely to be made up of accruals.


GL Brands Sloan Ratio % Historical Data

The historical data trend for GL Brands's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GL Brands Sloan Ratio % Chart

GL Brands Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19
Sloan Ratio %
Get a 7-Day Free Trial -421.43 -16,427.78 -47.63 -37.43 -50.36

GL Brands Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -31.14 -19.05 -18.64 -51.69 -114.50

Competitive Comparison of GL Brands's Sloan Ratio %

For the Drug Manufacturers - Specialty & Generic subindustry, GL Brands's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GL Brands's Sloan Ratio % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GL Brands's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where GL Brands's Sloan Ratio % falls into.



GL Brands Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

GL Brands's Sloan Ratio for the fiscal year that ended in Jun. 2019 is calculated as

Sloan Ratio=(Net Income (A: Jun. 2019 )-Cash Flow from Operations (A: Jun. 2019 )
-Cash Flow from Investing (A: Jun. 2019 ))/Total Assets (A: Jun. 2019 )
=(-12.731--3.443
--0.108)/18.227
=-50.36%

GL Brands's Sloan Ratio for the quarter that ended in Sep. 2019 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Sep. 2019 )
=(-26.373--4.057
--0.037)/19.458
=-114.50%

GL Brands's Net Income for the trailing twelve months (TTM) ended in Sep. 2019 was -1.712 (Dec. 2018 ) + -1.618 (Mar. 2019 ) + -8.531 (Jun. 2019 ) + -14.512 (Sep. 2019 ) = $-26.37 Mil.
GL Brands's Cash Flow from Operations for the trailing twelve months (TTM) ended in Sep. 2019 was -1.828 (Dec. 2018 ) + -0.54 (Mar. 2019 ) + -0.549 (Jun. 2019 ) + -1.14 (Sep. 2019 ) = $-4.06 Mil.
GL Brands's Cash Flow from Investing for the trailing twelve months (TTM) ended in Sep. 2019 was -0.112 (Dec. 2018 ) + -0.143 (Mar. 2019 ) + 0.148 (Jun. 2019 ) + 0.07 (Sep. 2019 ) = $-0.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GL Brands  (OTCPK:GRLB) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Sep. 2019, GL Brands has a Sloan Ratio of -114.50%, indicating earnings are more likely to be made up of accruals.


GL Brands Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of GL Brands's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


GL Brands (GL Brands) Business Description

Traded in Other Exchanges
N/A
Address
3939 Beltline Road, Suite 350, Addison, TX, USA, 75001
GL Brands Inc is a hemp consumer packaged goods company. It is engaged in the development and commercialization of a portfolio of brands that market and sell responsibly produced cannabinoid-rich products for health and well-being. The firm's portfolio of products consists of tinctures, softgels, gummies, sparkling beverages, vapes and others.
Executives
Rsgroberg Consulting Llc other: former director 1256 PANINI DRIVE, ATTN: RICHARD GROBERG, HENDERSON NV 89052
Pelosi Paul Francis Jr other: Former director 2269 CHESTNUT STREET, SAN FRANCISCO CA 94123
David Goldburg director 641 LEXINGTON AVENUE 18TH FLOOR NEW YORK NY 10020
Christopher Michael Sloan other: former COO 2755 W. PEBBLE ROAD #506 LAS VEGAS NV 89123
Joshua Martin Halford officer: CTO 5175 JERRY TARKANIAN WAY #16303 LAS VEGAS NV 89148
Raymond P Medeiros director 3571 E. SUNSET ROAD, SUITE 420 LAS VEGAS NV 89120
Clifford J Perry director, 10 percent owner, officer: CEO, CFO 3571 E. SUNSET ROAD, SUITE 420 LAS VEGAS NV 89120
Richard C. Cowan director, 10 percent owner 1300 DOVE STREET #215 NEWPORT BEACH CA 92660